BMC Cancer 2006, 6:10 http://www.biomedcentral.com/1471-2407/6/10 microarrays for high-throughput molecular profiling of tumour specimens. Nat Med 1998, 4:844-847. 14. Packeisen J, Buerger H, Krech R, Boecker W: Tissue microarrays: a new approach for quality control in immunohistochemis- try. J Clin Pathol 2002, 55(8):613-5. 15. Kaplan EL, Meier P: Nonparametric estimation from incom- plete observations. J Am Stat Ass 1958, 53:457-481. 16. Cox DR: Regression models and life-tables. JR Stat Soc [B] 1972, 34:187-202. 17. Watanabe S, Ichikawa E, Takahashi H, Otsuka F: Changes of cytok- eratin and involucrin expression in squamous cell carcino- mas of the skin during progression to malignancy. Br J Dermatol 1995, 132(5):730-9. 18. Morgan PR, Su L: Intermediate filaments in oral neoplasia. I. Oral cancer and epithelial dysplasia. Eur J Cancer B Oral Oncol 1994, 30B(3):160-6. Review 19. Chu PG, Weiss LM: Keratin expression in human tissues and neoplasms. Histopathology 2002, 40(5):403-39. 20. Vaidya MM, Sawant SS, Borges AM, Naresh NK, Purandare MC, Bhisey AN: Cytokeratin expression in human fetal tongue and buccal mucosa. J Biosci 2000, 25(3):235-42. 21. Crowe DL, Milo GE, Shuler CF: Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive poten- tial. J Dent Res 1999, 78(6):1256-63. 22. Depondt J, Shabana AH, Sawaf H, Gehanno P, Forest N: Cytokera- tin alterations as diagnostic and prognostic markers of oral and pharyngeal carcinomas. A prospective study. Eur J Oral Sci 1999, 107(6):442-54. 23. Vora HH, Shah NG, Patel DD, Trivedi TI, Chikhlikar PR: Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis. Br J Cancer 1996, 73(4):531-8. 24. Janot F, Klijanienko J, Russo A, Mamet JP, de Braud F, El-Naggar AK, Pignon JP, Luboinski B, Cvitkovic E: Prognostic value of clinico- pathological parameters in head and neck squamous cell car- cinoma: a prospective analysis. Br J Cancer 1996, 73(4):531-8. 25. Hansson A, Bloor BK, Sarang Z, Haig Y, Morgan PR, Stark HJ, Fusenig NE, Ekstrand J, Grafstrom RC: Analysis of proliferation, apopto- sis and keratin expression in cultured normal and immortal- ized human buccal keratinocytes. Eur J Oral Sci 2003, 111(1):34-41. 26. Chu YW, Seftor EA, Romer LH, Hendrix MJ: Experimental coex- pression of vimentin and keratin intermediate filaments in human melanoma cells augments motility. Am J Pathol 1996, 148(1):63-9. 27. Inada H, Izawa I, Nishizawa M, Fujita E, Kiyono T, Takahashi T, Momoi T, Inagaki M: Keratin attenuates tumor necrosis factor- induced cytotoxicity through association with TRADD. J Cell Biol 155(3):415-26. Epub 2001 Oct 29 28. Gilbert S, Loranger A, Daigle N, Marceau N: Simple epithelium keratins 8 and 18 provide resistance to Fas-mediated apop- tosis. The protection occurs through a receptor-targeting modulation. J Cell Biol 154(4):763-73. 2001 Aug 20 29. Oshima RG, Baribault H, Caulin C: Oncogenic regulation and function of keratins 8 and 18. Cancer Metastasis Rev 1996, 15(4):445-71. 30. Woelfle U, Sauter G, Santjer S, Brakenhoff R, Pantel K: Down-regu- lated expression of cytokeratin 18 promotes progression of human breast cancer. Clin Cancer Res 10(8):2670-4. 2004 Apr 15 31. Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, Nicholson RI, Ellis IO: Expression of luminal and basal cytok- eratins in human breast carcinoma. J Pathol 2004, 203(2):661-71. 32. Schaafsma HE, Van Der Velden LA, Manni JJ, Peters H, Link M, Rutter DJ, Ramaekers FC: Increased expression of cytokeratins 8, 18 and vimentin in the invasion front of mucosal squamous cell carcinoma. J Pathol 1993, 170(1):77-86. 33. Yuan CC, Huang HC, Tsai LC, Ng HT, Huang TS: Cytokeratin-19 associated with apoptosis and chemosensitivity in human cervical cancer cells. Apoptosis 1997, 2(1):101-5. 34. Parekh HK, Simpkins H: The differential expression of cytoker- atin 18 in cisplatin-sensitive and -resistant human ovarian adenocarcinoma cells and its association with drug sensitiv- ity. Cancer Res 55(22):5203-6. 1995 Nov 15 Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/6/10/prepub Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp BioMedcentral Page 8 of 8 (page number not for citation purposes)